Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC ...
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for ...
For primary care physicians, the question is increasingly whether continuous glucose data could answer a clinically useful ...
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while ...
The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Natera's multi-cancer early ...
Pauline M. Maki, PhD, reviews the first data cuts from OPTION-VMS, released at The Menopause Society 2025 meeting. These ...
Pauline M. Maki, PhD, introduces OPTION-VMS and explains why real-world data are needed to test whether randomized trial ...
Adolescents and young adults with sporadic colorectal cancer (CRC) most often present with stage III or IV disease, and only ...
The American College of Obstetricians & Gynecologists (ACOG) has published new clinical guidance on managing menopause-related vasomotor symptoms (VMS), sleep disturbance, and moo ...
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood ...
A multicomponent approach to vaccination distress works across the lifespan, though how it works depends on age, according to ...
In "Shared Decision-Making for Agitation in Specialty Care and Disease Trajectory," our experts close out the discussion of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results